What does clinically tested actually mean?

Much less than clinically proven. Tested can mean a small consumer perception study; proven implies controlled evidence. The gap between the two words is where most marketing lives.

What is the evidence hierarchy for a cosmetic claim?

From weakest to strongest: in vitro, ex vivo, consumer perception or use study, controlled instrumental study, and randomised controlled trial.

How is before-and-after photography manipulated?

Through lighting, styling, camera angle, parting and post-processing. The article shows what to look for when judging an eight-week results image.

What "Clinically Tested" Actually Means on a Hair Product Label

2026年8月17日

By Dr. Susan Lin, MD | MD HAIR | La Cañada Ventures, Inc. — The Physician Behind MD HAIR Series

You're holding two bottles. One says "clinically tested." The other says "clinically proven — 93% saw thicker hair in 8 weeks," and underneath there's a photograph of a woman's part line, before and after, and the after looks undeniably better.

You pick the second one. Of course you do. It gave you a number, a timeframe, and a picture. That's what evidence looks like.

I want to take that decision apart, because I sit on the other side of it. I commission these studies. I read the protocols, I see the raw data, and I have had the conversations where someone suggests a photograph be reshot "with better lighting." I know exactly how much — and how little — each of those phrases is required to mean.

I'm Dr. Susan F. Lin, M.D., trained at Boston University School of Medicine, double board-certified in Obstetrics & Gynecology and in Anti-Aging Medicine, and the physician behind the MD® line at La Cañada Ventures, Inc. since 2008. This article is going to give you a framework for reading any hair product's evidence claims. Then — and this is the part that matters — I am going to turn that framework on my own products and tell you plainly what our studies do and do not establish.

If that second half makes you trust us more, good. If it makes you decide our evidence isn't strong enough for you, that is a legitimate conclusion and you reached it with accurate information. Both outcomes are better than the alternative.

The Evidence Hierarchy, From Weakest to Strongest

1. In Vitro — "In Glass"

Cells, enzymes, or tissue fragments in a dish. An enzyme-inhibition assay showing a botanical compound interacts with 5-alpha reductase is in vitro.

What it establishes: that a molecule can do something to a biological target under controlled laboratory conditions.
What it does not establish: that the molecule reaches that target in a living human, at any relevant concentration, or that anything visible happens if it does. A dish has no stratum corneum, no circulation, no metabolism.

2. Ex Vivo — "Out of the Living"

Real human tissue — often hair follicles microdissected from surgical specimens — kept alive in organ culture. This is a genuine step up: the follicle retains its architecture and cell populations. Much of the most interesting mechanistic hair research lives here.

What it establishes: that an intact human follicle responds to a compound.
What it does not establish: anything about a follicle attached to a person, in a scalp, receiving the compound through skin.

Both of these are legitimate and necessary science. Neither is a clinical result, and any product that presents an in vitro or ex vivo finding without labelling it as such is misleading you — whether or not it intends to.

3. The Consumer Perception / Use Study

Now we're in humans. A group of participants uses the product for a defined period and answers structured questions: Does your hair look better? Is it easier to manage? Does it feel fuller? Results are reported as percentages of respondents agreeing.

What it establishes: that a defined group of real people, using the actual finished product for a real duration, reported a particular experience. That is not nothing. Consumer satisfaction, tolerability, and adherence are genuinely useful to know, and a product nobody wants to keep using cannot help anyone.

What it does not establish: anything measured. Nobody counted a hair. These are perceptions, typically unblinded, usually without a control group. Expectation shapes self-report powerfully — the placebo literature is unambiguous that subjective, self-reported outcomes are the outcome class most susceptible to it (Hróbjartsson & Gøtzsche, 2010).

A consumer use study is evidence about experience, not evidence about biology. Both matter. They are not interchangeable.

4. The Controlled Instrumental Study

Here we stop asking and start measuring, using validated methods:

Phototrichogram — a defined scalp area is clipped, sometimes dyed for contrast, photographed at high magnification at intervals, and hairs are counted and classified as anagen or telogen. It yields hair density, growth rate, and cycle-phase ratios (Van Neste, 2001).
TrichoScan — epiluminescence microscopy combined with automated digital image analysis, producing density, diameter, and anagen/telogen ratios with reduced observer subjectivity (Hoffmann, 2001).
Trichogram, phototrichogram variants, and standardized global photography — each with documented strengths and limitations, reviewed comprehensively by Dhurat and Saraogi (2009).

What it establishes: objective, quantitative change in a measurable hair parameter.
What it still may not establish: causation — unless there is a control group. Hair varies seasonally. People change their diet, sleep, and styling during a study. Simply being enrolled changes behavior.

5. The Randomized Controlled Trial

The top of the ladder. Participants are randomly assigned to product or control (placebo/vehicle), ideally with both participants and assessors blinded, outcomes pre-specified, and analysis conducted on all randomized participants. The CONSORT statement defines what complete reporting of such a trial requires (Schulz et al., 2010).

Randomization is what makes causal inference possible: it distributes known and unknown confounders across groups by chance rather than by hope. Blinding is what protects the outcome from expectation — the assessor's as much as the participant's. The pivotal minoxidil trials in androgenetic alopecia are examples of this tier done properly (Olsen et al., 2002).

This is what "proven" should mean. Almost nothing in the cosmetic hair category is at this tier, mine included.

The Language Game: "Tested" Versus "Proven"

"Clinically tested" means a test occurred. It says nothing about the result, the design, the size, or the outcome. A product that performed dismally in a study is, strictly speaking, clinically tested. The phrase describes an activity, not a finding — and it is popular precisely because it borrows the authority of the word "clinical" while committing to nothing.

"Clinically proven" asserts a demonstrated result and carries a substantially heavier substantiation burden. U.S. advertising law expects health-related claims to be supported by competent and reliable scientific evidence appropriate to the claim being made — and the FTC's guidance for health products is explicit that stronger claims require stronger substantiation (FTC Health Products Compliance Guidance, 2022).

"Dermatologist tested" usually means a dermatologist supervised an irritation or tolerability assessment. It is a safety statement, not an efficacy statement. Most consumers read it as the opposite.

"Results you can see" and similar phrasing are puffery — legally, non-factual claims no reasonable consumer would treat as a measurement.

Testimonials and before/after photos are governed by the FTC's Endorsement Guides, which require that endorsements reflect honest opinions and that atypical results be disclosed as such (16 CFR Part 255).

Reading the Small Print: n, Duration, Blinding, Control

How many people (n)? A study of 20 can generate a headline percentage that would evaporate in a larger sample. Small studies are noisy, and noise plus selective reporting is how implausible findings enter circulation (Ioannidis, 2005).

For how long? The hair cycle is measured in years. A meaningful density change cannot manifest in four weeks — the biology forbids it. Any density claim under roughly 12 weeks deserves outright skepticism; 24 weeks is a more honest window.

Was it blinded? If participants knew, self-reported outcomes are compromised. If assessors knew, even "objective" photo grading is compromised.

Was there a control? Without one, you cannot separate the product from time, season, behavior change, or enrollment itself.

If a brand's marketing gives you a percentage but none of these four details, the omission is the answer.

How "8 Week Results" Photography Is Manipulated

I want to be specific here, because photography is where the largest gap between impression and evidence lives — and none of the following requires a single altered pixel.

Lighting. Diffuse, frontal, soft light minimizes scalp show-through. Overhead or raking light casts shadow into the part and exaggerates it. Shooting "before" under harsh overhead light and "after" under soft frontal light produces a dramatic transformation in an unchanged head.

Part placement. Shift a part one centimeter to a denser region and density appears to increase. This is the single most common technique, and it is undetectable in the final image.

Wet versus dry. Wet hair clumps and separates, maximizing visible scalp. Dry, brushed hair covers. A wet "before" and a dry "after" is a complete transformation with zero biological change.

Styling, product, and color. Volumizing product, backcombing, blow-drying at the root, and fiber powders all add apparent density instantly. Darker root color reduces the contrast between hair and scalp, which is most of what "thin" looks like in a photograph.

Camera position and crop. Angle, distance, and focal length change how much scalp is in frame. So does tilting the head.

Selection. Photographing 40 participants and publishing the best three is not fraud, but it is not evidence either.

What honest photography looks like: identical lighting setup, identical camera and lens, fixed head position, same part line marked and reproduced, same wet-or-dry state, same styling, no product, same time of day, and — the mark of real seriousness — every participant's photographs published or made available, not a curated selection.

When you next see a dramatic before/after, ask which of those controls you can verify. Usually the answer is none.

Applying the Standard to MD's Own Evidence

I would be a hypocrite to publish everything above and then hide behind the same fog. So here is our evidence, described as I would describe a competitor's.

The Consumer Use Study

In a 30-day in-office consumer use study of MD Nutri Hair™ in 30 subjects, 95% saw improved hair appearance, 90% reported better manageability, and 75% reported increased fullness. Individual results vary; studies on file.

What this establishes: that participants using the finished product reported these experiences. It is real data from real people using the real product, and it speaks to satisfaction, tolerability, and adherence.

What this does not establish: it is a perception study. No hair was counted. No follicle was measured. It was not randomized and not placebo-controlled, so I cannot tell you what a control group would have reported — and per the placebo literature, self-reported outcomes are exactly the class where expectation exerts the most influence (Hróbjartsson & Gøtzsche, 2010). These figures are evidence of experience, not evidence of measured biological change, and I will not present them as the latter.

The 17-Week Spincontrol North America Study

For our topicals: in a 119-day (17-week) study of the two-step topical serum system conducted by Spincontrol North America in 24 participants, 71% agreed their hair growth had improved, and 75% said they would recommend the product. Individual results vary; study on file.

What this establishes: an independent third-party testing organization — not our marketing department — ran a study of meaningful duration. Seventeen weeks is long enough for hair-cycle changes to begin appearing, which is more than most category claims can say. Independence and duration are both genuine strengths, and I stand behind them.

What this does not establish: the study was open-label and self-reported, with no placebo group — and the report itself notes that the overall satisfaction rate was not significantly validated. It is not a hair count, not a shaft-diameter measurement, not a phototrichogram anagen/telogen ratio. It sits on the ladder above a simple in-house perception survey and below a controlled instrumental study. I am telling you that unprompted, because it is exactly the detail this article says to demand.

What We Do Not Claim

We do not say MD® products are FDA approved. They are not — they are cosmetics and dietary supplements, manufactured in FDA-registered, GMP-compliant facilities, which is a statement about the facility, not about product approval. We do not say our products treat, cure, or prevent androgenetic alopecia or any other disease, because they are not drugs and I would not make that claim if the law permitted it.

And when I discuss ingredient science, I label it as laboratory mechanism research, because that is the tier it occupies.

A Claim We Made, Checked, and Withdrew

The fastest way to show you what this standard actually costs is to apply it to something I got wrong.

Earlier versions of our copy said that lilac-derived verbascoside had been studied in the lab for its interaction with both Type I and Type II 5-alpha reductase. It read well. It was also, when we went back to the primary source, not supportable. The document behind that sentence was a supplier presentation, not a paper, and the paper it pointed to had tested caffeic acid and caffeic acid phenethyl ester — two fragments of the verbascoside molecule — rather than verbascoside itself. That paper does not mention verbascoside anywhere, and the fragment it did test came out selective for Type I by roughly fourfold, not active at both (Hiipakka et al., 2002). Read properly, the citation contradicted the claim it was supporting. We removed the sentence everywhere it appeared.

This is the tier problem from earlier in this article, in miniature and at my own expense. A supplier slide is not a study. A paper cited by a slide is not a paper about our ingredient. And "studied in the lab" is a phrase that sounds like a citation while doing none of a citation's work — which is precisely the trick I have spent this article asking you to watch for.

What the peer-reviewed literature does support for this molecule is narrower and, I think, more useful. In controlled laboratory studies on human dermal papilla cells — the cells at the base of the follicle — verbascoside induced cell proliferation, prevented testosterone-induced cell death, and reduced the release of pro-inflammatory signals including IL-1α, IL-6, IL-1β and TNF-α (Wisuitiprot et al., 2022). Two caveats belong in the same breath: these are cell studies rather than human trials, and the authors themselves state that clinical study is still needed. So does one more — that work used verbascoside from Acanthus, not from lilac. Same molecule, different botanical source; it is not a study of our own material, and I will not let it be read as one. The paper is open access, so you can check every sentence I just wrote against it, which is the whole point.

Could I run an RCT? A properly powered, controlled, instrumented trial is expensive and slow, and I would rather tell you honestly where our evidence sits today than imply we are somewhere we are not. That is the trade, stated out loud.

The Bottom Line

"Clinically tested" means a test happened. "Clinically proven" claims a result and requires substantiation appropriate to the claim. Between an in vitro assay and a randomized controlled trial lie three distinct tiers of evidence that answer genuinely different questions, and marketing language flattens all of them into a single reassuring word.

Ask four questions of any product's evidence: how many people, for how long, blinded or not, controlled or not. Treat photographic before/afters as unverifiable unless the brand documents lighting, part placement, wet/dry state, styling, and camera position — because every one of those can transform an image without changing a single hair.

Then apply the same standard to the products you're considering, including mine. Our consumer use study tells you what users experienced. Our 17-week third-party study tells you what participants observed over a duration long enough to matter. Neither is a randomized controlled trial, and you now know exactly what that distinction costs.

A brand willing to tell you the ceiling of its own evidence is giving you something more useful than a percentage.

Dr. Susan Lin's Clinical Perspective

"The most revealing question I can ask about any product's evidence is not 'what were the results' but 'what question was this study designed to answer.' A perception study answers 'did users like it.' A phototrichogram answers 'did hair density change.' A randomized controlled trial answers 'did the product cause the change.' Three different questions, three different levels of proof — and an industry that has learned to report the easiest one in language borrowed from the hardest. I run these studies. I know what ours establish, which is that people using our products report a better experience with their hair over durations long enough to be meaningful. I also know what they do not establish, which is causally demonstrated biological change against a control arm. Saying both sentences out loud costs me nothing I want to keep."

— Dr. Susan F. Lin, M.D., Physician Formulator, MD HAIR

Mechanism Spotlight: Why the Hair Cycle Makes Short Studies Meaningless

The reason study duration is not a technicality is written into follicle biology. A scalp follicle spends two to six years in anagen, about two weeks in catagen, roughly three months in telogen, and then releases its old shaft. At any moment, some 85–90% of your follicles are in anagen and 10–15% in telogen, and because those cycles are staggered, everyday shedding is a quiet background hum rather than an event. Any intervention acting on the cycle must therefore express itself through this timetable. A follicle nudged toward earlier anagen re-entry still has to shed its resting club hair, regrow a shaft through the follicular canal, and reach the surface — and shafts grow roughly one centimeter per month. Meaningful, measurable change in density or caliber simply cannot appear in four or eight weeks; the physiology has not had time to run. This is also why properly designed hair trials commonly report at 24 weeks or later and why hair evaluation methodology emphasizes cycle-phase measurement over snapshot appearance (Dhurat & Saraogi, 2009; Olsen et al., 2002). When you see "results in 30 days," you are not looking at a hair-cycle effect. You are looking at fiber cosmetics — conditioning, static reduction, surface smoothing — which are real, worth having, and something else entirely.

MD HAIR Product Recommendation

I'm not going to end a consumer-protection article by pushing a bottle at you. Instead, two links:

Read our evidence yourself. Our Clinical Evidence page sets out the consumer use study figures and the 17-week Spincontrol North America study, with the same framing used above: what each design establishes, and what it does not. If you want the studies on file, ask us. A brand that will not show you its evidence when asked has told you what you need to know.

Find out what you're actually dealing with first. Before any product, the useful step is identifying what is driving your hair change — hormonal transition, telogen effluvium, nutritional deficiency, androgenetic miniaturization, or several at once. The MD HAIR Quiz is a starting point for that reasoning, not a diagnosis. For an actual diagnosis, see your own physician, and ask for the labs: full thyroid panel, serum ferritin, vitamin D, and — where indicated — androgen studies (Guo & Katta, 2017).

Genuine MD HAIR™ and MD Nutri Hair™ products are sold only through mdhair.com, md-factor.com, and the official La Cañada Ventures stores on Amazon and Walmart. Products from other sellers cannot be verified by us for authenticity, storage, or lot integrity — and neither can any evidence claim made about them.

Learn more at mdhair.com/pages/clinical-evidence-hair

References (click to check)

Dr. Susan F. Lin, M.D. is the physician formulator behind MD HAIR and MD Nutri Hair™, product lines of La Cañada Ventures, Inc. — physician-formulated since 2008 under the MD® mark (U.S. Reg. No. 4,471,494). She trained at Boston University School of Medicine, is double board-certified in Obstetrics & Gynecology and in Anti-Aging Medicine, and is the named inventor on U.S. Patent No. 8,206,695.

MD® products are cosmetics and dietary supplements manufactured in FDA-registered, GMP-compliant facilities. They are not FDA approved and are not intended to diagnose, treat, cure, or prevent any disease. All study figures cited are from a 30-day in-office consumer use study (30 subjects) and a 119-day Spincontrol North America study (24 participants); studies on file. Individual results vary. This article is for educational purposes and does not constitute medical advice. Consult your own physician for personalized guidance.

Pregnancy and breastfeeding: because there are no clinical data in pregnant or breastfeeding women, we do not advocate using MD HAIR products during pregnancy or lactation.